The DOI matches its Crossref record; 87 of the 90 references it cites were found in a registry or an index.
Pathogenic LRRK2 mutations, through increased kinase activity, produce enlarged lysosomes with reduced degradative capacity and increase ATP13A2 expression
Abstract
Lysosomal dysfunction plays a central role in the pathogenesis of several neurodegenerative disorders, including Parkinson's disease (PD). Several genes linked to genetic forms of PD, including leucine-rich repeat kinase 2 (LRRK2), functionally converge on the lysosomal system. While mutations in LRRK2 are commonly associated with autosomal-dominant PD, the physiological and pathological functions of this kinase remain poorly understood. Here, we demonstrate that LRRK2 regulates lysosome size, number and function in astrocytes, which endogenously express high levels of LRRK2. Expression of LRRK2 G2019S, the most common pathological mutation, produces enlarged lysosomes and diminishes the lysosomal capacity of these cells. Enlarged lysosomes appears to be a common phenotype associated with pathogenic LRRK2 mutations, as we also observed this effect in cells expressing other LRRK2 mutations; R1441C or Y1699C. The lysosomal defects associated with these mutations are dependent on both the catalytic activity of the kinase and autophosphorylation of LRRK2 at serine 1292. Further, we demonstrate that blocking LRRK2's kinase activity, with the potent and selective inhibitor PF-06447475, rescues the observed defects in lysosomal morphology and function. The present study also establishes that G2019S mutation leads to a reduction in lysosomal pH and increased expression of the lysosomal ATPase ATP13A2, a gene linked to a parkinsonian syndrome (Kufor-Rakeb syndrome), in brain samples from mouse and human LRRK2 G2019S carriers. Together, these results demonstrate that PD-associated LRRK2 mutations perturb lysosome function in a kinase-dependent manner, highlighting the therapeutic promise of LRRK2 kinase inhibitors in the treatment of PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“a phenotype previously observed in association with lysosomal impairment41,42”
From Decreased lipidated ApoE‐receptor interactions confer protection against pathogenicity of ApoE and its lipid cargoes in lysosomes (2025) · cites this paper as [41]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Zhang, Y., Chen, K., Sloan, S. A., Bennett, M. L., Scholze, A. R., O'Keeffe, S., Phatnani, H. P., Guarnieri, P., Caneda, C., Ruderisch, N., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1860-14.2014 · Cited by 4,875
Regulation mechanisms and signaling pathways of autophagy
He, C., & Klionsky, D. J. (2009) · Annual Review of Genetics · doi:10.1146/annurev-genet-102808-114910 · Cited by 3,609
Lysosomes: fusion and function
Luzio, J. P., Pryor, P. R., & Bright, N. A. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2217 · Cited by 1,807
Signals from the lysosome: a control centre for cellular clearance and energy metabolism
Settembre, C., Fraldi, A., Medina, D. L., & Ballabio, A. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3565 · Cited by 1,755
Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function
Saftig, P., & Klumperman, J. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2745 · Cited by 1,648
ENDOCYTOSIS AND MOLECULAR SORTING
Mellman, I. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.575 · Cited by 1,551
Lysosomes and autophagy in cell death control
Kroemer, G., & Jäättelä, M. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1738 · Cited by 1,322
Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity
West, A. B., Moore, D. J., Biskup, S., Bugayenko, A., Smith, W. W., Ross, C. A., Dawson, V. L., & Dawson, T. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507360102 · Cited by 1,228
Lee, J.-H., Yu, W. H., Kumar, A., Lee, S., Mohan, P. S., Peterhoff, C. M., Wolfe, D. M., Martinez-Vicente, M., Massey, A. C., Sovak, G., et al. (2010) · Cell · doi:10.1016/j.cell.2010.05.008 · Cited by 1,212
Flagged first, then by citations
3 of the 90 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–244 of 244
Diagnosis and biomarkers of Parkinson's disease and related movement disorders
Ebada, M. A., Mouffokes, A., Imran, M. A., Hefnawy, M. T., Soliman, Y., El‐Samahy, M., Kamran, A., Umar, T. P., Amer, B. E., Elsayed, M., et al. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-16128-5.00003-7 · Cited by 1
Do, M. D., Tran, T. N., Le, L. H. G., & Phuong, T. (2025) · Neurogenetics · doi:10.1007/s10048-025-00840-9 · Cited by 1
Leucine-rich repeat kinase 2 (LRRK2) and Parkinson's disease: from genetics to pathobiology
Cogo, S., & Greggio, E. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815950-7.00001-1 · Cited by 1
Pharmacodynamic Markers of LRRK2 Inhibition in BiofluidsPreprint
Wang, S., Kelly, K., Schussler, N., Boularand, S., Dubois, L., Hsieh, F., Tengstrand, E., Brotchie, J. M., Koprich, J. B., & West, A. B. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.01.28.923557 · Cited by 1
LRP10 as a novel α-synuclein regulator in Lewy body diseasesPreprint
Mascaro, A. C., Grochowska, M. M., Boumeester, V., Dits, N. F. J., Bilgiҫ, E. N., Breedveld, G. J., Vergouw, L. J. M., de Jong, F. J., van Royen, M. E., Bonifati, V., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.12.540510 · Cited by 1
Morrison, R., Mihaylov, S. R., Luk, C. H., Rodgers, A., Athanasiadi, N., Morris, H. R., Pellegrino, E., Ultanir, S. K., & Gutierrez, M. G. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.27.559807 · Cited by 1
Meneses‐Salas, E., Arnold, M., Castellá, M., Hsieh, F., Fernández‐Santiago, R., Ezquerra, M., Garrido, A., Martí, M. J., Enrich, C., Pfeffer, S. R., et al. (2025) · eLife · doi:10.7554/elife.106330.1 · Cited by 1
LRRK2 Kinase Mediates Increased GCase Activity in Microglia in Response to Proinflammatory StimuliPreprint
MacDougall, E. J., Chen, C. X. ‐., Deneault, É., You, Z., Abdian, N., Durcan, T. M., Senkevich, K. A., Gan‐Or, Z., & Fon, E. A. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.10.681687 · Cited by 1
1492-1992: l'America da scoprire
Ottonello, P. P. (1992) · Filosofia oggi
Silke, J. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733756352.793575602
Interactome mapping reveals a role for LRP10 in autophagy and NDFIP1-mediated α-synuclein secretionPreprint
Mascaro, A. C., Ferraro, F., Boumeester, V., Breedveld, G. J., Dekkers, D. H. W., Vergouw, L. J. M., de Jong, F. J., Demmers, J., Bonifati, V., & Mandemakers, W. J. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.28.569009
Adetobi, T. E., Oluwamayowa, A., Oladosu, V. I., babtunde, S., Ogunmola, T., & moses, O. (2024) · Research Square · doi:10.21203/rs.3.rs-3996208/v1
Zhang, G., Wang, Y., Lin, J., Wang, B., Mohsin, A., Cheng, Z., Hao, W., Gao, W., Xu, H., & Guo, M. (2022) · Figshare · doi:10.6084/m9.figshare.20486819
Zhang, G., Wang, Y., Lin, J., Wang, B., Mohsin, A., Cheng, Z., Hao, W., Gao, W., Xu, H., & Guo, M. (2022) · Figshare · doi:10.6084/m9.figshare.20486810
Zhang, G., Wang, Y., Lin, J., Wang, B., Mohsin, A., Cheng, Z., Hao, W., Gao, W., Xu, H., & Guo, M. (2022) · Figshare · doi:10.6084/m9.figshare.20486816
Zhang, G., Wang, Y., Lin, J., Wang, B., Mohsin, A., Cheng, Z., Hao, W., Gao, W., Xu, H., & Guo, M. (2022) · Figshare · doi:10.6084/m9.figshare.20486813
Beckers, J., Tharkeshwar, A. K., Fumagalli, L., Contardo, M., Schoor, E. V., Fazal, R., Thal, D. R., Chandran, S., Mancuso, R., Bosch, L. V. D., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24159426
Zhang, G., Wang, Y., Lin, J., Wang, B., Mohsin, A., Cheng, Z., Hao, W., Gao, W., Xu, H., & Guo, M. (2022) · Figshare · doi:10.6084/m9.figshare.20486822
Beckers, J., Tharkeshwar, A. K., Fumagalli, L., Contardo, M., Schoor, E. V., Fazal, R., Thal, D. R., Chandran, S., Mancuso, R., Bosch, L. V. D., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24159423
Lysosomal pH Homeostasis and Parkinson’s Disease
温, 娜. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.1451672
Sandhu, J. K., Thakur, K., Cai, D., Péladeau, C. L., Hewitt, M., & Ghadban, W. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-22300-6.00055-3 · Cited by 1
Jong, H.-L., Yuen, K., Jin, D., Hoe, S. L. L., Ideris, A., Tan, C., Lam, S.-K., Lim, Y. M., & Cheong, S. (2025) · Biochemical Genetics · doi:10.1007/s10528-025-11174-4
Affective phenotypes in heterozygous LRRK2 R1441G knock-in mice
Ng, M. H. F., Lam, J. W. Y., Choi, Z. Y.-K., Liu, H., Ho, P. W., Lau, B. W.-M., & Yee, B. K. (2025) · Frontiers in Genetics · doi:10.3389/fgene.2025.1629897
The transcription factor SKN-1 drives lysosomal enlargement during aging to maintain function
Wang, X., Liu, H., Wang, X., Zhou, B. Z., Tang, H., & Pang, S. (2025) · PLoS Biology · doi:10.1371/journal.pbio.3003540
Meneses‐Salas, E., Castellá, M., Arnold, M., Hsieh, F., Fernández‐Santiago, R., Ezquerra, M., Garrido, A., Martí, M. J., Enrich, C., Pfeffer, S. R., et al. (2025) · eLife · doi:10.7554/elife.106330.2
Beckers, J., Tharkeshwar, A. K., Fumagalli, L., Contardo, M., Schoor, E. V., Fazal, R., Thal, D. R., Chandran, S., Mancuso, R., Bosch, L. V. D., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24159420
Wang, B., Zhang, G., Hu, Y., Mohsin, A., Chen, Z., Hao, W., Li, Z., Gao, W., Guo, M., & Xu, H. (2024) · Figshare · doi:10.6084/m9.figshare.24956023
Zhang, G., Wang, Y., Lin, J., Wang, B., Mohsin, A., Cheng, Z., Hao, W., Gao, W., Xu, H., & Guo, M. (2022) · Figshare · doi:10.6084/m9.figshare.20486804
Wang, B., Zhang, G., Hu, Y., Mohsin, A., Chen, Z., Hao, W., Li, Z., Gao, W., Guo, M., & Xu, H. (2024) · Figshare · doi:10.6084/m9.figshare.26664649
Wang, B., Zhang, G., Hu, Y., Mohsin, A., Chen, Z., Hao, W., Li, Z., Gao, W., Guo, M., & Xu, H. (2024) · Figshare · doi:10.6084/m9.figshare.26664640
Zhang, G., Wang, Y., Lin, J., Wang, B., Mohsin, A., Cheng, Z., Hao, W., Gao, W., Xu, H., & Guo, M. (2022) · Figshare · doi:10.6084/m9.figshare.20486807
Zhang, G., Wang, Y., Lin, J., Wang, B., Mohsin, A., Cheng, Z., Hao, W., Gao, W., Xu, H., & Guo, M. (2022) · Figshare · doi:10.6084/m9.figshare.20486801
Wang, B., Zhang, G., Hu, Y., Mohsin, A., Chen, Z., Hao, W., Li, Z., Gao, W., Guo, M., & Xu, H. (2024) · Figshare · doi:10.6084/m9.figshare.24956219
Zheng, Q., Lin, L., YiBiao, C., Peng, L., Huiqing, W., Daoqing, S., & Yu, L. (2026) · Frontiers in Genetics · doi:10.3389/fgene.2026.1632163
Arotçarena, M.-L. (2019) · theses.fr (ABES) · doi:10.70675/fc7ae442z6823z43c3z8ebazd4960299833b
A Systematic Review on Disease‐Modifying Therapies in Parkinsonian Disorders
Eijsvogel, P. P. N. M., Smits, L. M. G., Kremer, P. H. C., & Groeneveld, G. J. (2026) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.70315 · Cited by 1
LRRK2/LRRK1 interactions modulate Rab7 activity and inhibit lysosomal exocytosisPreprint
Merghani, M. M., Gerhardt, E., Hesse, M., Fahlbusch, C., Boecker, C. A., & Outeiro, T. F. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.12.731951
Mann, L., Herrera-Rodriguez, R., van der Walt, F. E., Brimacombe, K. R., Sadouki, S., Misteli, T., Kubben, N., & Padeken, J. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.04.742751
Sharp, R. C., Wall, S. C., Follett, J., Deng, I. B., & Farrer, M. J. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.16.745139
LRRK2: Molecular Mechanisms in Parkinson’s Disease
Arias-Carrión, Ó., Guerra‐Crespo, M., Ortuño‐Sahagún, D., & Ortega‐Robles, E. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27177606
Suenaga, S., Sakurai, M., Iwatsubo, T., & Kuwahara, T. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.11.750829
Abdelaziz, A. M., Fawzy, M. N., & Shokr, M. M. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06177-0
Swathy, B., LeSourd, K. S., & Yuan, S. H. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.109720
Metadata
- Authors
- Henry, A. G., Aghamohammadzadeh, S., Samaroo, H., Chen, Y., Mou, K., Needle, E., & Hirst, W. D.
- Affiliations
- Pfizer (United States) (US)
- Corresponding author
- Hirst, Warren D.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-08-06
- Volume
- 24
- Issue
- 21
- Pages
- 6013-6028
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2100867992
- Cited by
- 235
- References
- 90
- Citations by year
- 2026: 19 · 2025: 25 · 2024: 21 · 2023: 24 · 2022: 24 · 2021: 28 · 2020: 32 · 2019: 16 · 2018: 20 · 2017: 15 · 2016: 8 · 2015: 2
- FWCI
- 10.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Molecular Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of California, Davis
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Keywords
- LRRK2, Parkinson's disease, lysosomal dysfunction, LRRK2 kinase activity, LRRK2 G2019S mutation, autophosphorylation, ATP13A2, lysosomal pH, astrocytes, Kufor-Rakeb syndrome, LRRK2 inhibitors
- MeSH terms
- Leucine-Rich Repeat Serine-Threonine Protein Kinase-2, Adenosine Triphosphatases, Animals, Astrocytes, Brain, Cells, Cultured, Proton-Translocating ATPases, Humans, Hydrogen-Ion Concentration, Lysosomes, Membrane Proteins, Mice, Inbred C57BL, Mice, Transgenic, Mutation, Parkinson Disease, Phenotype, Phosphorylation, Up-Regulation, Protein Serine-Threonine Kinases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review